Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Classement en actions #16882
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Prix de l'action
$2.52
Capitalisation boursière
$274.65M
Changement (1 jour)
0.46%
Changement (1 an)
-56.11%
Pays
CN
Échange VISEN Pharmaceuticals (2561)

Catégorie

Historique du prix de l'action pour VISEN Pharmaceuticals (2561)
Prix de clôture le plus élevé : $2.51 le 2026-09-01

Prix de clôture le plus bas : $7.66 le 2025-03-01
Historique du prix de l'action de VISEN Pharmaceuticals de 2025 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -15.85%
2025 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.63%
IN
$215.70 26.53%
CH